Velsipity Interactions
There are 757 drugs known to interact with Velsipity (etrasimod), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 488 are major, 259 are moderate, and 10 are minor.
- View all 757 medications that may interact with Velsipity
- View Velsipity alcohol/food interactions (1)
- View Velsipity disease interactions (4)
Most frequently checked interactions
View interaction reports for Velsipity (etrasimod) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- apremilast
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- bosentan
- Braftovi (encorafenib)
- Breyanzi (lisocabtagene maraleucel)
- Brilinta (ticagrelor)
- Brineura (cerliponase alfa)
- Briumvi (ublituximab)
- Brukinsa (zanubrutinib)
- Bylvay (odevixibat)
- Cabenuva (cabotegravir / rilpivirine)
- Cablivi (caplacizumab)
- Calquence (acalabrutinib)
Velsipity alcohol/food interactions
There is 1 alcohol/food interaction with Velsipity (etrasimod).
Velsipity disease interactions
There are 4 disease interactions with Velsipity (etrasimod) which include:
Report options
More about Velsipity (etrasimod)
- Velsipity consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Humira
Humira is a tumor necrosis factor blocker that is used to treat many inflammatory conditions such ...
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Mesalamine
Mesalamine is used to treat mild to moderate ulcerative colitis and prevent the symptoms of ...
Hydrocortisone
Hydrocortisone systemic is used for addison's disease, adrenocortical insufficiency, asthma, acute ...
Budesonide
Budesonide oral is used to treat the following conditions with inflammation as a symptom ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
